The purpose of this study was to investigate the health effects of an adapted tennis-based exercise program, in middle-aged men with moderate risk of cardiovascular diseases (CVD). Fifteen men (44.9 ± 4.9 years) with two or more CVD risk factors, completed an eight-week health program that included a continuous tennisbased exercise protocol with constant and controlled intensity between 70%-85% of maximum heart rate and a standard nutritional orientation. Participants were assessed at the beginning and end of the exercise program for standard parameters related to CVD and the Framingham risk score, motor skills and cardiopulmonary fitness, peripheral inflammation (neopterin levels), oxidative stress (nitric oxide and carbonylated protein content), and mitochondrial function (lymphocyte complex I activity). Exercise improved muscle strength and power, speed, agility and flexibility, V O 2 max and metabolic equivalents. The participants experienced decreases in body mass index, waist circumference, total and LDL-cholesterol, and reduction in the Framingham Risk Score. Exercise also decreased peripheral oxidative stress and production of nitric oxide. In addition, the increased V O 2 at ventilatory threshold 1 correlated with enhanced mitochondrial activity in blood lymphocytes. The tennis-based exercise program adapted to sustaining moderate and constant intensity represents a valuable non-pharmacological intervention to prevent CVD.speed, muscle power and endurance, among others. Outdoor sports are motivating and enjoyable with high adherence levels [6].
objective population was hospitalized adult patients who require the placement of a urinary catheter. To estimate population size, the number of annual hospital discharges in the National Health System (INEGI, 2010-2015) as well as, the percentage of hospitalized patients who require a urinary catheter (Jiménez, et al, 2010) was used. Results: The mean annual cost per patient for the current scenario was $219.13 dlls. and for the future scenario was $216.80 dlls. Based on the adoption rate, time horizon and the estimated population, the annual mean budget impact in the current scenario was predicted to be $127,480,836 dlls, while the future scenario was $127,078,297 dlls. in year 5. In the future scenario, the use of Advance Lubricath® Foley Catheter Tray® generates savings for the Public Health Care System of $402,539 dlls, which represents a percentage saving of 0.0014% of the total public health budget. ConClusions: The results show that the use of the Advance Lubricath® Foley Catheter Tray®, assuming an adoption rate of 10% and increasing 10% each year, would result in significant cost savings for the Public Health Care System in Mexico.
predictors of non-conventional laparoscopic approach to leiomyoma hysterectomy. Our findings suggest that there is a differential access to LH procedures among the US population which may be, in part, a result of racial and socioeconomic differences and centralization of laparoscopy services in urban areas.
in both sexes. In our analysis we used descriptive statistics, independent samples t-test. Results: In 1990, standardized mortality in men 45-59 was the highest in fSU (n=15) 358.69/100,000, the lowest rate was found in WE (n=17) 143.67/100,000. It significantly decreased to 244.99/100,000 (-31.70%, n=11) and 50.29/100,000 (-65.00%, n=15) by 2014 respectively (p,0.05). In 1990, standardized mortality in women 45-59 was the highest in fSU (n=15) 99.78/100,000, the lowest rate was found in WE (n=17) 29.06/100,000. It significantly decreased to 56.26/100,000 (-43.61%, n=11) and 9.89/100,000 (-65.97%, n=15) by 2014 respectively (p,0.05). Mortality also decreased significantly (p,0.001) among men (-49.41%) and women (-50.57%) in EE between 1990 and 2014. Conclusions: A significant decline was detected in standardized mortality of IHD in both sexes aged 45-59 between the assessed time period. The highest improvement was observed in Western-European countries.
in both sexes. In our analysis we used descriptive statistics, independent samples t-test. Results: In 1990, standardized mortality in men 45-59 was the highest in fSU (n=15) 358.69/100,000, the lowest rate was found in WE (n=17) 143.67/100,000. It significantly decreased to 244.99/100,000 (-31.70%, n=11) and 50.29/100,000 (-65.00%, n=15) by 2014 respectively (p,0.05). In 1990, standardized mortality in women 45-59 was the highest in fSU (n=15) 99.78/100,000, the lowest rate was found in WE (n=17) 29.06/100,000. It significantly decreased to 56.26/100,000 (-43.61%, n=11) and 9.89/100,000 (-65.97%, n=15) by 2014 respectively (p,0.05). Mortality also decreased significantly (p,0.001) among men (-49.41%) and women (-50.57%) in EE between 1990 and 2014. Conclusions: A significant decline was detected in standardized mortality of IHD in both sexes aged 45-59 between the assessed time period. The highest improvement was observed in Western-European countries.
Objectives: To compare propofol and midazolam in adult intensive care patients in relation to length of ICU stay, length of mechanical ventilation (MV) and time until extubation. Methods: MEDLINE, EMBASE, LILACS and Cochrane databases were searched from inception until July 2019 to retrieve RCTs that compared propofol and midazolam use as sedatives in adult ICU patients. There was no language restriction. We extracted and combined data from studies that reported to length of ICU stay, length of MV and time until extubation. A random-effects, meta-analytic model was applied in all calculations. Cochrane collaboration tool and GRADE were used to assess bias and certainty of the outcomes of the included studies, respectively. Two groups of patients were analyzed: elective surgical patients and critically ill patients. Results: Elective surgical patients receiving propofol reduced ICU stay by 5.07 hours (MD -5.07; 95% CI -8.68 to -1.45; p ,0.006, I 2 = 41 %, 5 studies), MV time by 4.28 hours (MD -4.28; 95% CI -4.62 to -3.94 (p ,0.00001, I 2 = 0, 3 studies), extubation time by 1.92 hours (MD -1.92; 95% CI -2.71 to -1.13; p ,0.00001, I 2 = 89%, 9 studies) compared to patients receiving midazolam. Critically ill patients receiving propofol reduced extubation time by 32.68 hours (MD -32.68; 95% CI -48.37 to -16.98; p ,0.0001, I 2 = 97%, 7 studies) compared to patients receiving midazolam. GRADE was very low for all outcomes. Conclusions: We conclude that propofol is a safe sedation strategy for general and elective surgery patients in the ICU. It is associated with improved outcomes when compared to the use of midazolam. Our data is in accordance with the recent sedation guideline (PADIS) recommendations where propofol can be used as the first-line sedative in adult ICU patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.